Mitchell, D H <br/><br/>
Cytotoxicity against autologous, allogeneic, and xenogeneic tumor targets by human recombinant interleukin-2-activated lymphocytes from healthy dogs and dogs with lung tumors.  [electronic resource] 

 -  American journal of veterinary research  Jul 1991 
 - 1132-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0002-9645 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--therapy<br/>Animals<br/>Cytotoxicity, Immunologic<br/>Dog Diseases--therapy<br/>Dogs<br/>Immunotherapy, Adoptive<br/>Interleukin-2--pharmacology<br/>Killer Cells, Lymphokine-Activated--immunology<br/>Lung Neoplasms--secondary<br/>Lymphocytes--immunology<br/>Male<br/>Osteosarcoma--secondary<br/>Recombinant Proteins--pharmacology